Medicinal – Page 168

Analysis of the correlation between the distribution of microorganisms carried by Coix seed and fungal toxins, and the biological control of aflatoxin

mycolabadmin

Coix seeds are popular in traditional Chinese medicine and food, but they can become contaminated with harmful fungi that produce toxins called mycotoxins. This study examined which fungi grow in Coix seeds from different regions and found that certain bacteria called Bacillus can effectively prevent dangerous mold from growing and producing toxins. By using these beneficial bacteria, producers can keep Coix seeds safer for people to consume as medicine or food.

Anti-Influenza Activity of Medicinal Material Extracts from Qinghai–Tibet Plateau

mycolabadmin

Researchers tested extracts from traditional Tibetan medicinal plants, mushrooms, and lichens to see if they could fight influenza virus. They found that seven out of nine extracts could reduce influenza virus infection in laboratory cells, with a mushroom extract called Armillaria luteo-virens showing particularly strong antiviral effects. These results suggest that traditional medicinal materials from the Qinghai–Tibetan plateau could be valuable sources for developing new flu treatments that might work better against drug-resistant flu strains.

Vesicle inhibition reduces Candida biofilm resistance

mycolabadmin

Researchers found that common FDA-approved drugs designed to block vesicle production in human cells can also reduce the protective matrix that Candida fungus builds around itself in biofilms. By combining these vesicle-blocking drugs with the antifungal fluconazole, the scientists were able to kill biofilm-forming Candida more effectively than either treatment alone. This discovery suggests a new approach to treating stubborn fungal infections on medical devices like catheters, potentially eliminating the need to surgically remove infected equipment.

Monoclonal Antibodies Can Aid in the Culture-Based Detection and Differentiation of Mucorales Fungi—The Flesh-Eating Pathogens Apophysomyces and Saksenaea as an Exemplar

mycolabadmin

Researchers developed a new diagnostic tool using specially designed antibodies to quickly identify dangerous flesh-eating fungi (Apophysomyces and Saksenaea) that cause severe infections. These fungi are particularly difficult to diagnose because they don’t produce spores on standard laboratory cultures. The new test can identify these pathogens in just 24-48 hours, much faster than traditional methods, which is critical since these infections progress rapidly and require immediate treatment. This advancement is especially important for hospitals in developing countries where expensive diagnostic equipment is unavailable.

Growth Propagation of Liquid Spawn on Non-Woven Hemp Mats to Inform Digital Biofabrication of Mycelium-Based Composites

mycolabadmin

Researchers developed a method to grow mushroom mycelium (fungal threads) in liquid form and apply it to hemp mats to create sustainable building materials. By testing different growth conditions and concentrations, they found ways to control how fast the mycelium spreads and covers the surface. This liquid-based approach offers advantages over traditional methods because it allows for more precise application and better control of material properties.

Safety and Efficacy of a 48-Month Efinaconazole 10% Solution Treatment/Maintenance Regimen: 24-Month Daily Use Followed by 24-Month Intermittent Use

mycolabadmin

Researchers studied a 4-year treatment plan for toenail fungal infections using efinaconazole, an antifungal solution applied daily for 2 years, then 2-3 times weekly for another 2 years. The treatment was safe and effective, with all patients who achieved a cure maintaining it through the maintenance phase, and even some non-cured patients improving further. The study included many elderly patients, showing the treatment is safe across all age groups and could help prevent infection relapse.

Whole Genome Sequence of an Edible Mushroom Stropharia rugosoannulata (Daqiugaigu)

mycolabadmin

Scientists have decoded the complete genetic blueprint of the wine cap mushroom (Stropharia rugosoannulata), a popular edible mushroom grown worldwide. The research identified over 12,000 genes and discovered the mushroom contains powerful enzymes that break down plant material, explaining why it grows so well on straw and corn stalks. The study also revealed that different parts of the mushroom (cap and stem) have different functions, with stems focusing on energy production and caps on growth and development.

Clinical Outcomes of Micafungin for Invasive Fungal Infections in the Obese and Nonobese

mycolabadmin

This study examined whether obese patients treated with the antifungal drug micafungin for serious fungal infections had different outcomes compared to non-obese patients. Researchers reviewed 378 patient cases and found that both groups had similar success rates of about 50%, suggesting that the standard dose of micafungin works equally well in obese and non-obese patients. These findings suggest that doctors do not need to prescribe higher doses of micafungin specifically for obese patients, though more research is needed to fully understand how obesity affects antifungal treatment.

Nitric Oxide-Mediated Regulation of Chitinase Activity and Cadmium Sequestration in the Response of Schizophyllum commune to Cadmium Stress

mycolabadmin

A culinary mushroom called Schizophyllum commune can be harmed by cadmium pollution. When exposed to cadmium, the fungus produces nitric oxide, which causes enzymes called chitinases to become more active. These active enzymes break down the mushroom’s cell wall, allowing more cadmium to accumulate and ultimately damage the fungus’s growth. By reducing nitric oxide levels, scientists may be able to protect this mushroom from cadmium poisoning.

One-Pot Synthesis of Chiral Succinate Dehydrogenase Inhibitors and Antifungal Activity Studies

mycolabadmin

Scientists developed a new method to create potent antifungal medications that can protect crops from destructive fungal diseases. By carefully controlling the molecular structure (chirality) of the compounds, they created drugs that are significantly more effective and potentially less toxic than existing treatments. Testing showed that the new compound called (S)-5f works 76 times better against gray mold fungus than its mirror-image counterpart, similar to how your left and right hands have the same shape but can’t be superimposed.

Research Topic: Medicinal